Access cutting-edge hereditary angioedema treatment through this clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.
Access hereditary angioedema specialists in Scottsdale at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hereditary angioedema treatment provided free
KVD900-303 is an open-label, multicenter clinical trial in patients aged 2 to 11 years old with HAE Type I or II.
Sponsor: KalVista Pharmaceuticals, Ltd.
Check if you qualify for this hereditary angioedema clinical trial in Scottsdale, AZ
If you're searching for hereditary angioedema treatment options in Scottsdale, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Scottsdale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hereditary angioedema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.